1-149791413-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000566.4(FCGR1A):c.1021C>T(p.Leu341Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000437 in 1,602,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000566.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000136 AC: 2AN: 146778Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.00000829 AC: 2AN: 241284Hom.: 1 AF XY: 0.00 AC XY: 0AN XY: 131198
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1455282Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 723910
GnomAD4 genome AF: 0.0000136 AC: 2AN: 146778Hom.: 0 Cov.: 26 AF XY: 0.0000140 AC XY: 1AN XY: 71640
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.1021C>T (p.L341F) alteration is located in exon 6 (coding exon 6) of the FCGR1A gene. This alteration results from a C to T substitution at nucleotide position 1021, causing the leucine (L) at amino acid position 341 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at